SynCore Biotechnology Co.,Ltd reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 4.53 million compared to TWD 2.92 million a year ago. Net loss was TWD 26.4 million compared to TWD 33.97 million a year ago. Basic loss per share from continuing operations was TWD 0.86 compared to TWD 1.1 a year ago.
For the six months, sales was TWD 8.23 million compared to TWD 6.28 million a year ago. Net loss was TWD 50.32 million compared to TWD 76.34 million a year ago. Basic loss per share from continuing operations was TWD 1.64 compared to TWD 2.48 a year ago.